Figure 6.

Retinoblastoma (RB) 1 loss of heterozygosity (LOH) gene list is highly predictive of breast cancer patient outcome. Kaplan-Meier survival curves showing overall survival (OS) or relapse-free survival (RFS) by dividing the patients in thirds (a, c) or in halves (b, d) using the rank order average expression values of the RB-LOH signature using the NKI295 breast cancer data set.